(2r)-3,3-Difluoro-2-methyl-azetidine;hydrochloride, 98%, 1g

2,3-Dioxoindoline-5-carboxylic acid, 97.0%, 5g

[6-Chloro-5-(trifluoromethyl)pyridin-3-yl]boronic acid, 97%, 5g

3-Methyl-5-nitrobenzaldehyde, 95.0%, 1g

2-(3-Methoxyoxetan-3-yl)ethan-1-ol, 98%, 250mg

2,2'-(CYCLOPROPANE-1,1-DIYL)BIS(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE), 95%, 1g

2-Chloro-N-(4-morpholin-4-yl-phenyl)-acetamide, 10g

2-Hydroxy-3,5-dinitropyridine, 98.0%, 100g

GC capillary column ROTI®Cap-624, 30 m, 0.32 mm, 1.80 µm, 1 Piece(s)

(R)-tert-Butyl 4-amino-3,3-dimethylpiperidine-1-carboxylate, 95.0%, 5g

1H-BENZIMIDAZOLE-1-CARBOXYLIC ACID, 6-CHLORO-4-METHYL-, 1,1-DIMETHYLETHYL ESTER, 95%, 1g

Chromium(III) oxide, min. 98%, ultra pure, 100 g, plastic packaging.

4-Oxo-4-(2-trifluoromethylphenyl)butyric acid, 97.0%, 2g